SCHEMBL370469

SCHEMBL370469

COc1ccc(Cn2cc3c(n2)C(C(F)(F)F)CCc2sc(NC(=O)O)nc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.41
MAPT P10636 13/20 0.41
SMN1; SMN2 Q16637 6/20 0.41
TP53 P04637 5/20 0.41
RXFP1 Q9HBX9 2/20 0.40
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HPGD P15428 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
LMNA P02545 2/20 0.39
THRB P10828 2/20 0.39
XBP1 P17861 1/20 0.39
RAB9A P51151 2/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15260678 0.91 RXFP1 (0.41) ACHEMAPTSMN1; SMN2TP53RXFP1
SCHEMBL370449 0.84 MAPT (0.42) ACHEMAPTALDH1A1KDM4E
SCHEMBL370746 0.84 GRM4 (0.41) ACHESMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL369101 0.81 MAPT (0.47) MAPTSMN1; SMN2TP53RXFP1ALDH1A1
SCHEMBL15261475 0.80 RXFP1 (0.42) ACHEMAPTSMN1; SMN2TP53RXFP1
SCHEMBL370822 0.75 NPC1 (0.40) ACHEMAPTSMN1; SMN2TP53RXFP1
SCHEMBL368910 0.73 GRM4 (0.42) ACHEMAPTSMN1; SMN2TP53ALDH1A1
SCHEMBL369977 0.72 KDM4E (0.44) ACHEMAPTALDH1A1KDM4E
SCHEMBL366960 0.72 MAPT (0.44) MAPTSMN1; SMN2TP53RXFP1ALDH1A1
SCHEMBL370384 0.72 GRM4 (0.43) ACHEMAPTSMN1; SMN2TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593277-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX Pharma S.A. (CH) 2013-05-22 EP disclosed
WO-2012009000-A2 NOVEL FUSED PYRAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS ADDEX PHARMA S.A. (CH) 2012-01-19 WO disclosed